| human | Q5 |
| P7893 | CIÊNCIAVITAE ID | 451F-66A0-0CB1 |
| P2798 | Loop ID | 788671 |
| P496 | ORCID iD | 0000-0002-4548-3566 |
| P1053 | ResearcherID | V-8740-2019 |
| P1153 | Scopus author ID | 6603933955 |
| P735 | given name | Donatella | Q20001881 |
| Donatella | Q20001881 | ||
| P106 | occupation | researcher | Q1650915 |
| Q59647763 | A novel bcl-1/JH breakpoint from a patient affected by mantle cell lymphoma extends the major translocation cluster |
| Q63473138 | A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts |
| Q40177156 | Antiproliferative and apoptotic effects of two new gold(III) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitro. |
| Q39155870 | Bortezomib down-modulates the survival factor interferon regulatory factor 4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-associated fibroblasts. |
| Q57475961 | CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth |
| Q40593500 | CD26 expression correlates with a reduced sensitivity to 2'-deoxycoformycin-induced growth inhibition and apoptosis in T-cell leukemia/lymphomas. |
| Q33747241 | CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation. |
| Q77307649 | CD30L up-regulates CD30 and IL-4 expression by T cells |
| Q78493565 | CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts |
| Q74459525 | Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells |
| Q59647715 | Chemokine receptors as therapeutic tools in Hodgkin lymphoma: CCR4 and beyond |
| Q53122359 | Clinical-grade quality platelet-rich plasma releasate (PRP-R/SRGF) from CaCl2 -activated platelet concentrates promoted expansion of mesenchymal stromal cells. |
| Q77834027 | Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells |
| Q89578567 | Comment on "Fibroblasts in Nodular SclerosingClassical Hodgkin Lymphoma Are Defined by a Specific Phenotype and Protect Tumor Cells from Brentuximab-Vedotin Induced Injury" Cancers 2019, 11, 1687 |
| Q42987269 | Competitive reverse-transcriptase PCR: a useful alternative to northern blotting for quantitative estimation of relative abundances of specific mRNAs in precious samples. |
| Q52181394 | Differential expression of the RET gene in human acute myeloid leukemia. |
| Q42520173 | Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. |
| Q59647766 | Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease |
| Q64983758 | Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It. |
| Q39365959 | Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis |
| Q39236369 | Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity. |
| Q74562571 | Hodgkin's disease: a disorder of dysregulated cellular cross-talk |
| Q82651321 | IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion |
| Q70011360 | Immunoaffinity purification of rat liver transketolase: evidence for multiple forms of the enzyme |
| Q55375632 | Improved GMP compliant approach to manipulate lipoaspirates, to cryopreserve stromal vascular fraction, and to expand adipose stem cells in xeno-free media. |
| Q55021572 | Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer. |
| Q37212749 | Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate |
| Q35820996 | Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells. |
| Q33757605 | Interleukin 1 is an autocrine regulator of human endothelial cell growth |
| Q42465988 | Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia |
| Q38609223 | Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance |
| Q37686897 | New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status |
| Q64917014 | Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives. |
| Q38962397 | Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts. |
| Q38955522 | Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer. |
| Q43233942 | Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma. |
| Q39096701 | Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer. |
| Q43084076 | Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). |
| Q39300146 | Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy. |
| Q42335714 | Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells. |
| Q63473118 | Superoxide-driven NAD(P)H oxidation induced by EDTA-manganese complex and mercaptoethanol |
| Q97414889 | The CCL5/CCR5 Axis in Cancer Progression |
| Q39007554 | The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma. |
| Q37763027 | The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. |
| Q37541911 | The inflammatory chemokine CCL5 and cancer progression |
| Q73481560 | The role of eosinophils in the pathobiology of Hodgkin's disease |
| Q78674107 | The role of interleukin-3 and stem cell factor in classical Hodgkin disease |
| Q35994955 | The role of interleukin-3 in classical Hodgkin's disease. |
| Q36951215 | The role of the EGFR signaling in tumor microenvironment. |
| Q39400978 | Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics. |
Search more.